Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist-Reference-Cited by-同舟云学术

Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist

Published:2019-03-21 Issue:5 Volume:36 Page:1031-1051
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Patel Dhiren,Triplitt Curtis,Trujillo Jennifer

Funder

Sanofi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-019-00907-8.pdf

Reference80 articles.

1. World Health Organization. Global report on diabetes. 2016. http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf?ua=1 . Accessed 23 July 2018.

2. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55:1577–96.

3. International Diabetes Federation Guideline Development Group. Global guideline for type 2 diabetes. Diabetes Res Clin Pract. 2014;104:1–52.

4. Davies MJ, D’Alessio DA, Fradkin J, et al. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018;61:2461–98.

5. Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2018 executive summary. Endoc Practice. 2018;24:91–120.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

2. Advances in the management of type 2 diabetes in adults;BMJ Medicine;2023-09

3. Glycaemic control and therapeutic inertia in patients with CAD and T2DM: a cross-sectional study in the Department of Cardiology;2022-12-06

4. Addressing Overbasalization to Achieve Glycemic Targets;ADCES in Practice;2022-01-31

5. iGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post‐hoc analysis of the LixiLan JP‐L trial;Journal of Diabetes Investigation;2021-06-19